▶ 調査レポート

臨床試薬の世界市場見通し2023年-2029年

• 英文タイトル:Clinical Reagents Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが調査・発行した産業分析レポートです。臨床試薬の世界市場見通し2023年-2029年 / Clinical Reagents Market, Global Outlook and Forecast 2023-2029 / MRC2312MG08429資料のイメージです。• レポートコード:MRC2312MG08429
• 出版社/出版日:Market Monitor Global / 2023年12月
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥487,500 (USD3,250)▷ お問い合わせ
  Enterprise User¥731,250 (USD4,875)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートは次の情報を含め、世界の臨床試薬市場規模と予測を収録しています。・世界の臨床試薬市場:売上、2018年-2023年、2024年-2029年
・世界の臨床試薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の臨床試薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「クロマトグラフィー試薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

臨床試薬のグローバル主要企業は、Danaher、 Roche、 Thermo Fisher Scientific、 Merck、 Abbott、 BioMerieux、 BD、 Siemens Healthcare、 Sysmex、 Bio-Rad Laboratories、 Lonza Group、 Agilent Technologies、 PerkinElmer、 Meridian Life Science、 Promega、 Watersなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、臨床試薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の臨床試薬市場:タイプ別、2018年-2023年、2024年-2029年
世界の臨床試薬市場:タイプ別市場シェア、2022年
・クロマトグラフィー試薬、体外診断用試薬、PCR試薬キット、細胞&組織培養用試薬、その他

世界の臨床試薬市場:用途別、2018年-2023年、2024年-2029年
世界の臨床試薬市場:用途別市場シェア、2022年
・公立病院、私立病院

世界の臨床試薬市場:地域・国別、2018年-2023年、2024年-2029年
世界の臨床試薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における臨床試薬のグローバル売上、2018年-2023年
・主要企業における臨床試薬のグローバル売上シェア、2022年
・主要企業における臨床試薬のグローバル販売量、2018年-2023年
・主要企業における臨床試薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Danaher、 Roche、 Thermo Fisher Scientific、 Merck、 Abbott、 BioMerieux、 BD、 Siemens Healthcare、 Sysmex、 Bio-Rad Laboratories、 Lonza Group、 Agilent Technologies、 PerkinElmer、 Meridian Life Science、 Promega、 Waters

*************************************************************

・調査・分析レポートの概要
臨床試薬市場の定義
市場セグメント
世界の臨床試薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の臨床試薬市場規模
世界の臨床試薬市場規模:2022年 VS 2029年
世界の臨床試薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの臨床試薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の臨床試薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:クロマトグラフィー試薬、体外診断用試薬、PCR試薬キット、細胞&組織培養用試薬、その他
臨床試薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:公立病院、私立病院
臨床試薬の用途別グローバル売上・予測

・地域別市場分析
地域別臨床試薬市場規模 2022年と2029年
地域別臨床試薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Danaher、 Roche、 Thermo Fisher Scientific、 Merck、 Abbott、 BioMerieux、 BD、 Siemens Healthcare、 Sysmex、 Bio-Rad Laboratories、 Lonza Group、 Agilent Technologies、 PerkinElmer、 Meridian Life Science、 Promega、 Waters
...

This research report provides a comprehensive analysis of the Clinical Reagents market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Clinical Reagents market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Clinical Reagents, challenges faced by the industry, and potential opportunities for market players.
The global Clinical Reagents market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Clinical Reagents market presents opportunities for various stakeholders, including Public Hospitals, Private Hospitals. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Clinical Reagents market. Additionally, the growing consumer demand present avenues for market expansion.
The global Clinical Reagents market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Clinical Reagents market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Clinical Reagents market.
Market Overview: The report provides a comprehensive overview of the Clinical Reagents market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Chromatography Reagents, IVD Diagnostics Reagents), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Clinical Reagents market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Clinical Reagents market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Clinical Reagents market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Clinical Reagents market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Clinical Reagents market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Clinical Reagents market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Clinical Reagents, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Clinical Reagents market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Clinical Reagents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chromatography Reagents
IVD Diagnostics Reagents
PCR Reagent Kits
Cell&Tissue Culture Reagents
Others
Market segment by Application
Public Hospitals
Private Hospitals
Global Clinical Reagents Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Danaher
Roche
Thermo Fisher Scientific
Merck
Abbott
BioMerieux
BD
Siemens Healthcare
Sysmex
Bio-Rad Laboratories
Lonza Group
Agilent Technologies
PerkinElmer
Meridian Life Science
Promega
Waters
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Reagents, market overview.
Chapter 2: Global Clinical Reagents market size in revenue.
Chapter 3: Detailed analysis of Clinical Reagents company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Reagents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

レポート目次

1 Introduction to Research & Analysis Reports
1.1 Clinical Reagents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Clinical Reagents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Clinical Reagents Overall Market Size
2.1 Global Clinical Reagents Market Size: 2022 VS 2029
2.2 Global Clinical Reagents Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Clinical Reagents Players in Global Market
3.2 Top Global Clinical Reagents Companies Ranked by Revenue
3.3 Global Clinical Reagents Revenue by Companies
3.4 Top 3 and Top 5 Clinical Reagents Companies in Global Market, by Revenue in 2022
3.5 Global Companies Clinical Reagents Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical Reagents Players in Global Market
3.6.1 List of Global Tier 1 Clinical Reagents Companies
3.6.2 List of Global Tier 2 and Tier 3 Clinical Reagents Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Clinical Reagents Market Size Markets, 2022 & 2029
4.1.2 Chromatography Reagents
4.1.3 IVD Diagnostics Reagents
4.1.4 PCR Reagent Kits
4.1.5 Cell&Tissue Culture Reagents
4.1.6 Others
4.2 By Type – Global Clinical Reagents Revenue & Forecasts
4.2.1 By Type – Global Clinical Reagents Revenue, 2018-2023
4.2.2 By Type – Global Clinical Reagents Revenue, 2024-2029
4.2.3 By Type – Global Clinical Reagents Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Clinical Reagents Market Size, 2022 & 2029
5.1.2 Public Hospitals
5.1.3 Private Hospitals
5.2 By Application – Global Clinical Reagents Revenue & Forecasts
5.2.1 By Application – Global Clinical Reagents Revenue, 2018-2023
5.2.2 By Application – Global Clinical Reagents Revenue, 2024-2029
5.2.3 By Application – Global Clinical Reagents Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Clinical Reagents Market Size, 2022 & 2029
6.2 By Region – Global Clinical Reagents Revenue & Forecasts
6.2.1 By Region – Global Clinical Reagents Revenue, 2018-2023
6.2.2 By Region – Global Clinical Reagents Revenue, 2024-2029
6.2.3 By Region – Global Clinical Reagents Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Clinical Reagents Revenue, 2018-2029
6.3.2 US Clinical Reagents Market Size, 2018-2029
6.3.3 Canada Clinical Reagents Market Size, 2018-2029
6.3.4 Mexico Clinical Reagents Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Clinical Reagents Revenue, 2018-2029
6.4.2 Germany Clinical Reagents Market Size, 2018-2029
6.4.3 France Clinical Reagents Market Size, 2018-2029
6.4.4 U.K. Clinical Reagents Market Size, 2018-2029
6.4.5 Italy Clinical Reagents Market Size, 2018-2029
6.4.6 Russia Clinical Reagents Market Size, 2018-2029
6.4.7 Nordic Countries Clinical Reagents Market Size, 2018-2029
6.4.8 Benelux Clinical Reagents Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Clinical Reagents Revenue, 2018-2029
6.5.2 China Clinical Reagents Market Size, 2018-2029
6.5.3 Japan Clinical Reagents Market Size, 2018-2029
6.5.4 South Korea Clinical Reagents Market Size, 2018-2029
6.5.5 Southeast Asia Clinical Reagents Market Size, 2018-2029
6.5.6 India Clinical Reagents Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Clinical Reagents Revenue, 2018-2029
6.6.2 Brazil Clinical Reagents Market Size, 2018-2029
6.6.3 Argentina Clinical Reagents Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Clinical Reagents Revenue, 2018-2029
6.7.2 Turkey Clinical Reagents Market Size, 2018-2029
6.7.3 Israel Clinical Reagents Market Size, 2018-2029
6.7.4 Saudi Arabia Clinical Reagents Market Size, 2018-2029
6.7.5 UAE Clinical Reagents Market Size, 2018-2029
7 Clinical Reagents Companies Profiles
7.1 Danaher
7.1.1 Danaher Company Summary
7.1.2 Danaher Business Overview
7.1.3 Danaher Clinical Reagents Major Product Offerings
7.1.4 Danaher Clinical Reagents Revenue in Global Market (2018-2023)
7.1.5 Danaher Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Clinical Reagents Major Product Offerings
7.2.4 Roche Clinical Reagents Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Clinical Reagents Major Product Offerings
7.3.4 Thermo Fisher Scientific Clinical Reagents Revenue in Global Market (2018-2023)
7.3.5 Thermo Fisher Scientific Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Clinical Reagents Major Product Offerings
7.4.4 Merck Clinical Reagents Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Clinical Reagents Major Product Offerings
7.5.4 Abbott Clinical Reagents Revenue in Global Market (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 BioMerieux
7.6.1 BioMerieux Company Summary
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux Clinical Reagents Major Product Offerings
7.6.4 BioMerieux Clinical Reagents Revenue in Global Market (2018-2023)
7.6.5 BioMerieux Key News & Latest Developments
7.7 BD
7.7.1 BD Company Summary
7.7.2 BD Business Overview
7.7.3 BD Clinical Reagents Major Product Offerings
7.7.4 BD Clinical Reagents Revenue in Global Market (2018-2023)
7.7.5 BD Key News & Latest Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Company Summary
7.8.2 Siemens Healthcare Business Overview
7.8.3 Siemens Healthcare Clinical Reagents Major Product Offerings
7.8.4 Siemens Healthcare Clinical Reagents Revenue in Global Market (2018-2023)
7.8.5 Siemens Healthcare Key News & Latest Developments
7.9 Sysmex
7.9.1 Sysmex Company Summary
7.9.2 Sysmex Business Overview
7.9.3 Sysmex Clinical Reagents Major Product Offerings
7.9.4 Sysmex Clinical Reagents Revenue in Global Market (2018-2023)
7.9.5 Sysmex Key News & Latest Developments
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Company Summary
7.10.2 Bio-Rad Laboratories Business Overview
7.10.3 Bio-Rad Laboratories Clinical Reagents Major Product Offerings
7.10.4 Bio-Rad Laboratories Clinical Reagents Revenue in Global Market (2018-2023)
7.10.5 Bio-Rad Laboratories Key News & Latest Developments
7.11 Lonza Group
7.11.1 Lonza Group Company Summary
7.11.2 Lonza Group Business Overview
7.11.3 Lonza Group Clinical Reagents Major Product Offerings
7.11.4 Lonza Group Clinical Reagents Revenue in Global Market (2018-2023)
7.11.5 Lonza Group Key News & Latest Developments
7.12 Agilent Technologies
7.12.1 Agilent Technologies Company Summary
7.12.2 Agilent Technologies Business Overview
7.12.3 Agilent Technologies Clinical Reagents Major Product Offerings
7.12.4 Agilent Technologies Clinical Reagents Revenue in Global Market (2018-2023)
7.12.5 Agilent Technologies Key News & Latest Developments
7.13 PerkinElmer
7.13.1 PerkinElmer Company Summary
7.13.2 PerkinElmer Business Overview
7.13.3 PerkinElmer Clinical Reagents Major Product Offerings
7.13.4 PerkinElmer Clinical Reagents Revenue in Global Market (2018-2023)
7.13.5 PerkinElmer Key News & Latest Developments
7.14 Meridian Life Science
7.14.1 Meridian Life Science Company Summary
7.14.2 Meridian Life Science Business Overview
7.14.3 Meridian Life Science Clinical Reagents Major Product Offerings
7.14.4 Meridian Life Science Clinical Reagents Revenue in Global Market (2018-2023)
7.14.5 Meridian Life Science Key News & Latest Developments
7.15 Promega
7.15.1 Promega Company Summary
7.15.2 Promega Business Overview
7.15.3 Promega Clinical Reagents Major Product Offerings
7.15.4 Promega Clinical Reagents Revenue in Global Market (2018-2023)
7.15.5 Promega Key News & Latest Developments
7.16 Waters
7.16.1 Waters Company Summary
7.16.2 Waters Business Overview
7.16.3 Waters Clinical Reagents Major Product Offerings
7.16.4 Waters Clinical Reagents Revenue in Global Market (2018-2023)
7.16.5 Waters Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer